Dr. Lois Jovanovič - in partnership with Sansum Diabetes Research Institute, Dr. Denice Feig of Mount Sinai Hospital, and JDRF - seeks women with type 1 diabetes who are planning pregnancy or are in their first trimester of pregnancy to participate in the CONCEPTt trial
SANTA BARBARA, Calif. (June 5, 2014) - Sansum Diabetes Research Institute
is looking for Santa Barbara area women with Type 1 diabetes - and who are preparing for pregnancy or are in their first trimester of pregnancy - to participate in an international research study. The trial, known as CONCEPTt, compares the effects of adding Continuous Glucose Monitoring (CGM) to standard therapy versus standard therapy alone.
Before and during pregnancy, women with Type 1 diabetes work hard to keep their blood sugars as normal as possible to avoid complications with the baby. It is not yet clear if Continuous Glucose Monitors can help. This international study is designed to look at the effect of using CGM before and during pregnancy.
Dr. Jovanovič is the principal investigator of the trial at Sansum Diabetes Research Institute. Dr. Denice Fieg is the lead investigator of the trial, which is sponsored by JDRF (formerly Juvenile Diabetes Research Foundation) and the Ontario and Canadian government.
Women interested in participating in the trial are encouraged to contact the Sansum Diabetes Research Institute using the following information:
Sansum Diabetes Research Institute
2219 Bath Street
Santa Barbara, CA 93105
(805) 682-7640, ext. 203
ABOUT SANSUM DIABETES RESEARCH INSTITUTE
Our singular daily focus is to improve the health and quality of life for men, women and children in Santa Barbara County - and millions around the world - who suffer from diabetes. We have been on the cutting edge of diabetes research, clinical care, and education since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes. Sansum Diabetes Research Institute advances new technologies and produces groundbreaking diabetes treatments, such as the development of an artificial pancreas that enables the automated delivery of insulin to patients.
Understanding that diet and lifestyle factors are key to the effective management and prevention of diabetes, the Institute offers education to the more than 40,000 Santa Barbara County residents impacted by the disease. The Institute also provides direct clinical care to patients, such as pregnant women with diabetes, helping them to deliver healthy babies.